As for the 12 individuals with clinical presumptive diagnosis of dystrophinopathy but without identified pathogenic mutation, we could determine that five of them had a biopsy with immunohistochemistry compatible with dystrophinopathy (dystrophin deficient or absent). The gene discussed is DMD; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.